CATALYST PHARMACEUTICALS, INC.·4

Feb 17, 5:00 PM ET

COELHO PHILIP H 4

4 · CATALYST PHARMACEUTICALS, INC. · Filed Feb 17, 2023

Insider Transaction Report

Form 4
Period: 2023-02-15
Transactions
  • Award

    Restricted Stock Units

    2023-02-154,000310,500 total
    Common Stock (4,000 underlying)
  • Exercise/Conversion

    Common stock, par value $0.001 per share

    2023-02-15+4,000154,887 total
Footnotes (3)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting.
  • [F2]Derivative securities vest in equal tranches, 1/3rd on February 14, 2023, 1/3rd on February 14, 2024 and 1/3rd on February 14, 2025.
  • [F3]Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on February 15, 2023.

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4 FOR 02-15-2023